Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains

NCT01631071 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Crucell Holland BV